Company / SG&A Expense
Lunai Bioworks Inc. SG&A Expense History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$1.2M
FY2017
5-year range
$38.7K / $1.6M
FY2013-FY2017
Trend
-25.2%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$1M in FY2017 with a 3-year CAGR of -0.1%.
Remained stable around $1M over the past 3 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -0.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -0.1%, indicating a declining trend.
- In FY2017, sg&a expense decreased 25.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | $1.2M | -25.2% |
| FY2016 | $1.6M | +33.3% |
| FY2014 | $1.2M | +3089.5% |
| FY2011 | $38.7K | - |
As of FY2017 · SEC 10-K · Updated Jun 24, 2026